Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Mega Genomics Limited ( (HK:6667) ) has provided an announcement.
Mega Genomics Limited has confirmed a final ordinary dividend of RMB 0.15 per share for the financial year ended 31 December 2025, following shareholder approval scheduled for 21 May 2026. The dividend will be paid in Hong Kong dollars, with the exact HKD amount and exchange rate to be announced, and no withholding tax is currently applicable.
The company has updated its dividend payment timetable, setting 26 May 2026 as the ex-dividend date and 29 May 2026 as the record date, with payment due on 6 July 2026. The clarified schedule provides greater visibility for shareholders on cash returns and may support investor confidence in the company’s capital-return policy and financial position.
More about Mega Genomics Limited
Mega Genomics Limited is a Hong Kong–listed company in the genomics and biotechnology sector. Its shares trade on the Main Board of the Stock Exchange of Hong Kong under stock code 06667, and it serves investors through the Hong Kong share registration system managed by Tricor Investor Services Limited.
Average Trading Volume: 7,078
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$1.57B
For an in-depth examination of 6667 stock, go to TipRanks’ Overview page.